Adalimumab in the Treatment of Chronic Pouchitis (ADAP)
Adalimumab (Humira) in the Treatment of Chronic Pouchitis
Sponsor: Aarhus University Hospital
Listed as NCT01670240, this PHASE3 trial focuses on Pouchitis and Ulcerative Colitis and remains completed. Sponsored by Aarhus University Hospital, it has been updated 6 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE3
First recorded
Aug 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Aarhus University Hospital
- AbbVie
- Hvidovre University Hospital
- Odense University Hospital
- University of Southern Denmark
For direct contact, visit the study record on ClinicalTrials.gov .